“Innovative DendrisChips® Technology for a Syndromic Approach of In Vitro Diagnosis: Application to the Respiratory Infectious Diseases” See publication
“Multiplexing technology for in vitro diagnosis of pathogens: the key contribution of phosphorus dendrimers” by Jean Pierre Majoral View publication
Since February 2018, Dendris has tested its device on two news partner pilot site, Gen-Bio Gravanches, in Clermont Ferrand and Biolab avenir in Toulouse.
RICAI is a well known congress dedicated to infectious diseases. Dendris will present its molecular diagnosis devices on december 2018 17th and 18th at the palais des congress in Paris. http://www.ricai.fr